Significant product quality differences were observed with a change in cell culture platform used to generate a CHO-derived monoclonal antibody.  Studies were performed to match the material generated before the platform transition. Media and process adjustments were employed to modulate product quality attributes to achieve the desired ranges. Results from these studies will be discussed in the presentation.<br/>

Achieving desired product quality for a CHO-derived monoclonal antibody

253rd National Meeting (2017)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.